Competition solves an awful lot of problems, and we just do not have the competition, and certainly not in the PBM markets.
Ron Johnson
The Public Record
Ron Harold Johnson is an American businessman and politician currently serving as the junior United States senator from Wisconsin, a position he has held since January 3, 2011. A member of the Republican Party, Johnson has focused on issues such as fiscal responsibility, healthcare reform, and government accountability during his tenure in the Senate. He has been an outspoken advocate for reducing the federal deficit and has often emphasized the need for economic growth through private sector initiatives.
The biggest problem with PBMs is we have Medicare and their formularies, and it makes it so unbelievably complex.
The biggest problem with PBMs is we have Medicare and their formularies, and it makes it so unbelievably complex.
I think PBMs--this is a really interesting hearing, okay? But if you eliminate all the profitability and all the incentives for creating new drugs, you have not really made a dent in our health-care spend.
Competition solves an awful lot of problems, and we just do not have the competition, and certainly not in the PBM markets.
Then the economy will take care of it. If it's cheaper, we'll move investments towards those cheaper energy sources.
So let me ask. Who is doing these studies? I mean what kind of government grants are they getting from the agencies that want to prove climate change?
The costs that I've listened to in these five hearings pale, I mean pale in comparison to what we've already I would say wasted, $5 trillion trying to hold back the tides.
So let me ask. Who is doing these studies? I mean what kind of government grants are they getting from the agencies that want to prove climate change?
We've already spent $5 trillion and haven't even moved the mark because the rest of the world is going to continue to do fossil fuels.
We've already spent $5 trillion and haven't even moved the mark because the rest of the world is going to continue to do fossil fuels.
The costs that I've listened to in these five hearings pale, I mean pale in comparison to what we've already I would say wasted, $5 trillion trying to hold back the tides.
If you let in the competitive market system with consumers participating in it, you will get price transparency just as a natural part of it.
I think PBMs--this is a really interesting hearing, okay? But if you eliminate all the profitability and all the incentives for creating new drugs, you have not really made a dent in our health-care spend.
Competition solves an awful lot of problems, and we just do not have the competition, and certainly not in the PBM markets.
The biggest problem with PBMs is we have Medicare and their formularies, and it makes it so unbelievably complex.
Then the economy will take care of it. If it's cheaper, we'll move investments towards those cheaper energy sources.





